Top Banner

of 15

Ppt Cml1 - Copy

Apr 08, 2018

Download

Documents

mettu_555
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/6/2019 Ppt Cml1 - Copy

    1/15

  • 8/6/2019 Ppt Cml1 - Copy

    2/15

  • 8/6/2019 Ppt Cml1 - Copy

    3/15

    Leukemic white blood cells in CMLcontain a Philadelphia (Ph)

    chromosome.

    The Ph chromosome is the result of

    a translocation between the longarms of chromosomes 9 and 22.

    This exchange brings together twogenes:

    TheBCR gene on chromosome 22 andthe proto-oncogene ABL on

    chromosome 9.

    Nowell PC (2007).

  • 8/6/2019 Ppt Cml1 - Copy

    4/15

    Nowell PC (2007).

  • 8/6/2019 Ppt Cml1 - Copy

    5/15

    Because many people with early CML have nosymptoms, about half of CML cases are detected

    when a person visits a doctor for a routinecheckup or blood test.

    CML

    Fatigue

    WeightLoss

    Swellingof thespleen

    Bruising

  • 8/6/2019 Ppt Cml1 - Copy

    6/15

    y Blood cell counts

    yBlood cell examination. A person with CML has a smallnumber of developing cells called "blast cells" in his or herblood. Blast cells are not found in the blood of healthy individuals.

    y CML is diagnosed by detecting the Philadelphiachromosome detected by FISH or PCR for bcr-abl fusiongene.

  • 8/6/2019 Ppt Cml1 - Copy

    7/15

    In chronic phase CML,fewer than 10% of cells inblood and bone marrow are blast cells and there maybe no symptoms of leukemia.

    Chronic

    average duration of5 to 6 years

    In accelerated phase of CML ,10% to 20% of the cellsof blood and bone marrow are blast cells. Patientsmay have fever, poor appetite and weight loss.

    Accelerated

    average duration of

    6 to 9 months

    In this phase,20% or more cells are blast cells.Symptoms such as anemia and recurring infectionsare typical.

    Blast

    Average durationof 3 to 6 months

  • 8/6/2019 Ppt Cml1 - Copy

    8/15

    yChemotherapy

    Bone marrow transplantation

    Removal of the spleen

    The newest treatment is Gleevec, a

    therapy that is believed to interfere with theaction of the abnormalities in CML whiteblood cells.

  • 8/6/2019 Ppt Cml1 - Copy

    9/15

    GLEEVEC IMATINIB STI-571

    Vigneri P et al., 2001

  • 8/6/2019 Ppt Cml1 - Copy

    10/15

    y CML accounts for approximately 15% of allleukemia's , with 4,000 to 5,000 new cases

    diagnosed in the United States annually.y The incidence of CML is 1.6 to 2.0 cases per

    100,000 persons per year, and the incidence issimilar in all countries worldwide.

    yWith the average age of people with CMLaround 66 years, CML mostly affects adults.

    y 2 percent of CML patients are children.

  • 8/6/2019 Ppt Cml1 - Copy

    11/15

    CML

    Monosomiesof

    chromosome7,17,Y

    Trisomies ofchromosomes

    8,17,21

    Translocations e.g.,

    T(3;21) etc.

    Abnormalitiesof

    P53,RB1,IRF4,

    cMYC,RAS,

    p16INK4A

    Jose Toma et al., 2007

  • 8/6/2019 Ppt Cml1 - Copy

    12/15

    To determine the mutations ofirf-4 gene in

    chronic myeloid patients (CML).

    Why mutation

    . If we know the nature and position ofmutation we will be able to benefit in thenear future from different therapies that

    target specific mutations.

  • 8/6/2019 Ppt Cml1 - Copy

    13/15

    IRF-4/MUM1/LSIRF Location ( 6p25.3) Gene of 19.4 Kb with 9 exons and 8 introns

  • 8/6/2019 Ppt Cml1 - Copy

    14/15

    Collection of blood samples

    Extraction of DNA

    Genotyping

    Polymerase Chain Reaction

    Agarose Gel Electrophoresis

    Statistical Analysis

  • 8/6/2019 Ppt Cml1 - Copy

    15/15